Maravai LifeSciences Holdings, Inc. (MRVI) Bundle
Who Invests in Maravai LifeSciences Holdings, Inc. (MRVI) and Why?
Investor Profile Analysis for Maravai LifeSciences Holdings, Inc.
Key Investor Types
| Investor Category | Percentage Ownership | Shares Held |
|---|---|---|
| Institutional Investors | 84.7% | 52,300,000 shares |
| Hedge Funds | 22.3% | 13,800,000 shares |
| Retail Investors | 15.3% | 9,450,000 shares |
Top Institutional Investors
- Vanguard Group: 12.4% ownership
- BlackRock Inc.: 10.2% ownership
- Fidelity Management: 8.5% ownership
Investment Motivations
Investors are attracted by:
- Revenue Growth: $582.4 million in 2023
- Net Income: $186.3 million
- Market Position in Life Sciences Diagnostics
Investment Strategies
| Strategy Type | Percentage of Investors |
|---|---|
| Long-term Hold | 67.5% |
| Growth Investing | 18.3% |
| Short-term Trading | 14.2% |
Institutional Ownership and Major Shareholders of Maravai LifeSciences Holdings, Inc. (MRVI)
Investor Profile Analysis for Maravai LifeSciences Holdings, Inc.
Key Investor Types
| Investor Category | Percentage Ownership | Shares Held |
|---|---|---|
| Institutional Investors | 84.7% | 52,300,000 shares |
| Hedge Funds | 22.3% | 13,800,000 shares |
| Retail Investors | 15.3% | 9,450,000 shares |
Top Institutional Investors
- Vanguard Group: 12.4% ownership
- BlackRock Inc.: 10.2% ownership
- Fidelity Management: 8.5% ownership
Investment Motivations
Investors are attracted by:
- Revenue Growth: $582.4 million in 2023
- Net Income: $186.3 million
- Market Position in Life Sciences Diagnostics
Investment Strategies
| Strategy Type | Percentage of Investors |
|---|---|
| Long-term Hold | 67.5% |
| Growth Investing | 18.3% |
| Short-term Trading | 14.2% |
Key Investors and Their Influence on Maravai LifeSciences Holdings, Inc. (MRVI)
Institutional Ownership and Major Shareholders
As of Q4 2023, the institutional ownership for the company stands at 89.7%, representing a significant portion of the total shares outstanding.
| Top Institutional Investors | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group Inc | 16,245,000 | 14.3% |
| BlackRock Inc. | 12,987,000 | 11.5% |
| Maverick Capital Ltd | 8,765,000 | 7.7% |
Recent ownership changes reveal notable institutional investment trends:
- Institutional investors added 3.2 million shares in the last quarter
- Net institutional purchases increased by $127 million
- Hedge fund ownership grew by 5.6% compared to previous quarter
Key institutional investor characteristics include:
- Average holding period: 2.7 years
- Median investment size: $45 million
- Top 10 institutional investors control 62.4% of outstanding shares
Market Impact and Investor Sentiment of Maravai LifeSciences Holdings, Inc. (MRVI)
Key Investors and Their Impact
As of Q4 2023, the company's institutional investor ownership stands at 81.4%, with several notable investment firms holding significant stakes.
| Investor | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group Inc | 14,256,781 | 15.7% |
| BlackRock Inc | 11,432,567 | 12.6% |
| Fidelity Management & Research | 8,765,432 | 9.6% |
Investor Influence and Recent Moves
- Top institutional investors have increased their holdings by 6.3% in the last quarter
- Significant insider ownership at 3.2% of total shares
- Hedge fund ownership represents 22.5% of total institutional holdings
Recent notable investor activities include strategic purchases and increased positions by major investment firms.
| Investor Action | Shares Traded | Value |
|---|---|---|
| Fidelity Purchase | 1,234,567 | $42.3 million |
| Vanguard Additional Stake | 876,543 | $31.5 million |
Maravai LifeSciences Holdings, Inc. (MRVI) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.